✦ LIBER ✦

Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive, Locally Advanced, or Metastatic Breast Cancer

✍ Scribed by Miller, K. D.; Dieras, V.; Harbeck, N.; Andre, F.; Mahtani, R. L.; Gianni, L.; Albain, K. S.; Crivellari, D.; Fang, L.; Michelson, G.; de Haas, S. L.; Burris, H. A.

Book ID: 125520131
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 148 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2013.52.6590

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Randomized Study of Trastuzumab

Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

✍ Hurvitz, S. A.; Dirix, L.; Kocsis, J.; Bianchi, G. V.; Lu, J.; Vinholes, J.; Gua 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

A phase 1 study of weekly dosing of tras

A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2–positive breast cancer

✍ Muralidhar Beeram; Ian E. Krop; Howard A. Burris; Sandhya R. Girish; Wei Yu; Mic 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Pertuzumab Monotherapy After Trastuzumab

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

✍ Cortes, J.; Fumoleau, P.; Bianchi, G. V.; Petrella, T. M.; Gelmon, K.; Pivot, X. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 497 KB

Feasibility and pharmacokinetics of comb

Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancer

✍ Suzuki, Yasuhiro; Ogiya, Rin; Oshitanai, Risa; Terao, Mayako; Terada, Mizuho; Mo 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 288 KB

8N Similar outcome in a randomized phase

✍ M. Andersson; E. Lidbrink; E. Wist; K. Enevoldsen; A.B. Jensen; P.G. Sørensen; K 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Overall Survival Benefit With Lapatinib

Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study

✍ Blackwell, K. L.; Burstein, H. J.; Storniolo, A. M.; Rugo, H. S.; Sledge, G.; Ak 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 203 KB